ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Achaogen seeks near-term sale through bankruptcy process
April 17, 2019Achaogen is looking to sell its assets and close out its affairs through the bankruptcy process. News of the Chapter 11 filing comes 10 months after Achaogen won FDA approval for its antibiotic Zemdri. -
Achaogen wields ax on R&D, C-suite as antibiotic launch gets underway
July 30, 2018The impact of Achaogen’s narrower-than-expected label for antibiotic Zemdri is now apparent: The biotech has slashed 28% of its staff and all but two R&D programs. -
Achaogen Receives Investment from Gates Foundation
May 09, 2017Achaogen announced it has signed an agreement with the Bill & Melinda Gates Foundation to prevent neonatal sepsis in developing countries through the generation of monoclonal antibodies against gram-negative bacteria.
Pharma Sources Insight January 2025
